Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beauvais
Clinical trial register · France

Clinical Trials in Beauvais, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Federation Francophone de Cancerologie Digestive6 UNICANCER5 University Hospital, Rouen3 GERCOR - Multidisciplinary Oncology Cooperative Group2 University Hospital, Lille2
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Beauvais

29 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Active, closed
University Hospital, Lille
Observational
500
Abbeville, Amiens, Arras, Beauvais, Beuvry, Béthune, Boulogne, Calais
2026-04-20
Recruiting
Federation Francophone de Cancerologie Digestive
Not applicable
300
Poitiers, Albi, Amiens, Annecy, Aurillac, Bayeux, Bayonne, Beauvais
2026-03-10
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
74
Angers, Arras, Auxerre, Bayeux, Bayonne, Beauvais, Besançon, Beuvry
2025-12-31
Recruiting
UNICANCER
Phase 3
3,902
Amiens, Angers, Argenteuil, Aurillac, Auxerre, Avignon, Bayonne, Beauvais
2025-12-18
Recruiting
University Hospital, Rouen
Phase 3
188
Amiens, Beauvais, Besançon, Bicêtre, Bordeaux, Clermont-Ferrand, Lille, Marseille
2025-09-25
Recruiting
AbbVie
Observational
700
Dijon, Niort, Romans-sur-Isère, Beauvais, Le Mans, Toulon, Boulogne-Billancourt
2025-09-09
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Angers, Annecy, Antony, Aurillac, Bayeux, Bayonne, Beauvais, Besançon
2025-08-31
By invitation
UNICANCER
Phase 2
80
Amiens, Auxerre, Avignon, Bayonne, Beauvais, Blois, Boulogne-sur-Mer, Brest
2025-07-30
Recruiting
University Hospital, Grenoble
Not applicable
300
Annonay, Auriol, Beauvais, Cap-d'Ail, Castelnaudary, Dolus-d'Oléron, Dommartin, Embrun
2024-12-03
Recruiting
University Hospital, Rouen
Phase 3
232
Amiens, Beauvais, Besançon, Bobigny, Caen, Clamart, Colmar, Dijon
2024-05-07
Recruiting
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
NCT06541652Hepatocholangiocarcinoma, Fibrolamellar Carcinoma, Hepatic Epithelioid Hemangioendothelioma, Hepatoblastoma
Federation Francophone de Cancerologie Digestive
Observational
150
Amiens, Angers, Beauvais, Besançon, Béthune, Bobigny, Caen, Calais
2024-03-26
Recruiting
Federation Francophone de Cancerologie Digestive
Observational
600
Bayonne, Beauvais, Besançon, Boujan-sur-Libron, Boulogne-sur-Mer, Chambéry, Cholet, Compiègne
2024-02-12
Recruiting
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NCT05639413Metastatic Colorectal Cancer, BRAF V600E Mutation Positive
UNICANCER
Not applicable
400
Avignon, Bayeux, Beauvais, Bordeaux, Bourg-en-Bresse, Cahors, Calais, Caluire-et-Cuire
2023-07-24
Active, closed
UNICANCER
Phase 2
118
Amiens, Arras, Avignon, Beauvais, Besançon, Brest, Cholet, Clermont-Ferrand
2023-06-23
Active, closed
Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants
NCT05768295Surgical Operation, Edentulous Jaw, Edentulous Mouth, Implant
Anthogyr
Not applicable
200
Annecy, Beauvais, Cadaujac, Draguignan, Le Bouscat, Marseille, Moulins, Royan
2023-04-05
Recruiting
Association Francaise d'Urologie
Observational
8,000
Aix-en-Provence, Angers, Arras, Aubergenville, Beauvais, Caen, Cesson-Sévigné, Cornebarrieu
2023-02-21
Active, closed
Sandoz
Observational
562
Amiens, Auxerre, Bayonne, Beauvais, Brest, Caen, Castelnau-le-Lez, Clermont-Ferrand
2023-02-16
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Amiens, Angers, Auxerre, Avignon, Beauvais, Besançon, Bordeaux, Brest
2022-04-15
Recruiting
University Hospital, Rouen
Not applicable
204
Beauvais, Amiens, Besançon, Bobigny, Brest, Caen, Clermont-Ferrand, Créteil
2021-06-11
Active, closed
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
NCT03806309Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer
DrugsTedopi·Folfox·Fluorouracil·Irinotecan
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
106
Amiens, Beauvais, Besançon, Bordeaux, Brest, Creil, Créteil, Dijon
2021-04-10
Recruiting
University Hospital, Lille
Phase 3
248
Amiens, Arras, Beauvais, Béthune, Caen, Calais, Dunkirk, Le Quesnoy
2021-03-01
Recruiting
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420Squamous Cell Carcinoma of Head and Neck
Centre Henri Becquerel
Not applicable
138
Amiens, Beauvais, Caen, Le Havre, Lille, Rouen, Saint-Quentin
2020-11-26
Recruiting
Unity Health Toronto
Not applicable
740
Amiens, Angers, Argenteuil, Beauvais, Bordeaux, Brest, Cholet, Créteil
2020-11-23
Active, closed
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.
NCT03828227Elderly Patients, Metastatic Colorectal Cancer, Quality of Life
DrugsAvastin·Capecitabine·Bevacizumab
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3
49
Abbeville, Amiens, Beauvais, Boulogne-sur-Mer, Cannes, Compiègne, Creil, Créteil
2019-06-14
Recruiting
Ictal Group
Observational
1,000
Angoulême, Beauvais, Beuvry, Brest, Brive-la-Gaillarde, Cannes, Cherbourg, Clichy
2018-02-28
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
348
Angers, Antony, Avignon, Bayonne, Beauvais, Bordeaux, Caluire-et-Cuire, Challans
2016-12
Recruiting
UMC Utrecht
Phase 3
20,000
Argenteuil, Aurillac, Beauvais, Belfort, Béthune, Boulogne-Billancourt, Dax, Dieppe
2016-04-11
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Angers, Auch, Avignon, Bayonne, Beauvais, Blois, Bordeaux, Brest
2011-02-28
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 1 November 2026. https://priyalifescience.com/clinical-trials-france/city/beauvais

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Beauvais.

How many clinical trials are recruiting in Beauvais?

18 of the 29 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 2 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beauvais), 29 studies
PhaseStudiesRecruitingShare
Phase 310734.5%
Not applicable7624.1%
Observational7524.1%
Phase 25017.2%

Most active sponsors

Lead sponsors with the most studies (Beauvais)
Lead sponsorStudiesRecruiting
Federation Francophone de Cancerologie Digestive64
UNICANCER53
University Hospital, Rouen33
GERCOR - Multidisciplinary Oncology Cooperative Group20
University Hospital, Lille21
AbbVie11
Anthogyr10
ARCAGY/ GINECO GROUP10
Association Francaise d'Urologie11
Centre Henri Becquerel11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.